Who can enroll in the registry?

• Patients with a personal history of ovarian granulosa cell tumors including adult type granulosa cell tumors, juvenile type granulosa cell tumors, and mixed granulosa cell tumors.
• Patients of all ages except neonates are eligible.
• Patients may be in any stage of treatment, surveillance, or recurrence at the time of initial participation in the study.
• Patients who are receiving or have received treatment at any facility, including but not limited to MD Anderson Cancer Center are eligible.
• Patient may be residents of any country and be of any ethnic background.
• Patients who enroll must be able to read and speak English, or else be assisted by an institutional MD Anderson Cancer Center interpreter.
• Legally Authorized Representatives of deceased patients can contact the registry study team to inquire about potential enrollment for these patients.